UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
Clinical trial NCT07155369 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07155369
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-18
- Primary completion
- 2026-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.